VKTX stock

Viking Therapeutics Inc (VKTX) earnings · $3.97B cap

These earnings events as JSON? API free 100/day

Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.

This VKTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported VKTX revenue for 2025-12-31 was $0. Net income was -$359.6M. VKTX currently screens at market cap $3.97B.

When the next VKTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

Period-over-period revenue change is not in cache for VKTX. We will not invent a beat or miss.

Not investment advice. Full VKTX research stays on the stock page; the tape stays on the quote page.

VKTX earnings FAQ

What is VKTX's latest net income?

Latest cached Viking Therapeutics Inc (VKTX) net income was -$359.6M. Statements: https://lician.com/financials/vktx

What is VKTX's latest diluted EPS?

Latest cached Viking Therapeutics Inc (VKTX) diluted EPS for Dec 31, 2025 was -$3.19.

What period does the latest VKTX earnings print cover?

The latest cached Viking Therapeutics Inc (VKTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

Where are VKTX earnings listed?

Cached earnings facts for Viking Therapeutics Inc (VKTX) are listed at https://lician.com/earnings/vktx. Statements: https://lician.com/financials/vktx

Not investment advice.

Full VKTX analysis